ADAMTS17 | ADAM metallopeptidase with thrombospondin type 1 motif, 17 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Mixed |
ADAMTS2 | ADAM metallopeptidase with thrombospondin type 1 motif, 2 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Mixed |
ADAMTS4 | ADAM metallopeptidase with thrombospondin type 1 motif, 4 | Cancer-related genes Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
ADAMTS8 | ADAM metallopeptidase with thrombospondin type 1 motif, 8 | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTSL1 | ADAMTS-like 1 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Mixed |
ADAMTSL4 | ADAMTS-like 4 | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
ADCK1 | AarF domain containing kinase 1 | Enzymes Predicted secreted proteins
| | | | | Expressed in all |
ADCK2 | AarF domain containing kinase 2 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ADCY1 | Adenylate cyclase 1 (brain) | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
ADCY10 | Adenylate cyclase 10 (soluble) | Cytoskeleton related proteins Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
ADCY2 | Adenylate cyclase 2 (brain) | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ADCY3 | Adenylate cyclase 3 | Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ADCY4 | Adenylate cyclase 4 | Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
ADCY5 | Adenylate cyclase 5 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ADCY6 | Adenylate cyclase 6 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ADCY7 | Adenylate cyclase 7 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
ADCY8 | Adenylate cyclase 8 (brain) | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
ADCY9 | Adenylate cyclase 9 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ADCYAP1R1 | Adenylate cyclase activating polypeptide 1 (pituitary) receptor type I | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Group enriched |
ADH1B | Alcohol dehydrogenase 1B (class I), beta polypeptide | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
ADH4 | Alcohol dehydrogenase 4 (class II), pi polypeptide | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
ADH5 | Alcohol dehydrogenase 5 (class III), chi polypeptide | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ADH6 | Alcohol dehydrogenase 6 (class V) | Enzymes Predicted intracellular proteins
| | | | | Tissue enriched |
ADIG | Adipogenin | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ADIPOR1 | Adiponectin receptor 1 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ADIPOR2 | Adiponectin receptor 2 | Predicted membrane proteins
| | | | | Expressed in all |
ADORA1 | Adenosine A1 receptor | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ADORA2A | Adenosine A2a receptor | Cancer-related genes FDA approved drug targets G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
ADORA2B | Adenosine A2b receptor | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
ADORA3 | Adenosine A3 receptor | FDA approved drug targets G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ADPRM | ADP-ribose/CDP-alcohol diphosphatase, manganese-dependent | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ADRA1A | Adrenoceptor alpha 1A | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
ADRA1B | Adrenoceptor alpha 1B | Cancer-related genes FDA approved drug targets G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ADRA1D | Adrenoceptor alpha 1D | FDA approved drug targets G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ADRA2A | Adrenoceptor alpha 2A | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
ADRA2B | Adrenoceptor alpha 2B | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
ADRA2C | Adrenoceptor alpha 2C | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
ADRB1 | Adrenoceptor beta 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
ADRB2 | Adrenoceptor beta 2, surface | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Mixed |
ADRB3 | Adrenoceptor beta 3 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
ADRBK1 | Adrenergic, beta, receptor kinase 1 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ADRBK2 | Adrenergic, beta, receptor kinase 2 | Enzymes Predicted intracellular proteins
| | | | | Mixed |
ADTRP | Androgen-dependent TFPI-regulating protein | Predicted membrane proteins
| | | | | Tissue enhanced |
AF196779.12 | PRA1 family protein 2 {ECO:0000313|Ensembl:ENSP00000451962}; Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000365536} | Predicted membrane proteins
| | | | | Not detected |
AFG3L2 | AFG3-like AAA ATPase 2 | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
AGER | Advanced glycosylation end product-specific receptor | Cancer-related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
AGL | Amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
AGMO | Alkylglycerol monooxygenase | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
AGPAT1 | 1-acylglycerol-3-phosphate O-acyltransferase 1 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
AGPAT2 | 1-acylglycerol-3-phosphate O-acyltransferase 2 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |